Pegvisomant (Somavert) for acromegaly.
D000172:Acromegaly / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D019382:Human Growth Hormone / Q000031:analogs & derivatives / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D011986:Receptors, Somatotropin / Q000037:antagonists & inhibitors* / Q000502:physiology
D011986:Receptors, Somatotropin; D019382:Human Growth Hormone; C406545:pegvisomant